Insulinoma. From a Difficult Diagnosis to Complete Recovery. Case Report
Abstract
Objective: Insulinomas are tumors of very low incidence. However, it is considered the most common tumor cause of hypoglycemia. Their diagnosis can be difficult since they present with symptoms that can be related to multiple entities causing hypoglycemia such as the supply of exogenous insulin, drug consumption, among others. Therefore, clinical suspicion and paraclinical and imaging identification are required to achieve adequate and timely management. The objective of this article is to document and describe a case of insulinoma, from the difficulties in diagnosis, clinical prognosis, and therapeutic approach.
Case description: The case of a patient with a history of type 2 diabetes mellitus with the appearance of symptomatic hypoglycemia is presented. After the diagnostic process, an insulinoma was identified in a timely manner for subsequent surgical resection with complete improvement of the patient's symptoms.
Conclusion: The identification and timely diagnosis of insulinomas promote early intervention to improve the quality of life of patients and avoid possible complications.
Downloads
Disciplines:
Health ScienciesReferences
Iglesias P, Lafuente C, Martin MA, López A, Castro JC, Díez Juan José. Insulinoma: Análisis multicéntrico y retrospectivo de la experiencia de 3 décadas (1983-2014). Edocrinol Nutr. 2015;63(7):306-313. DOI: https://www.elsevier.es/es-revista-endocrinologia-nutricion-12-articulo-insulinoma-analisis-multicentrico-retrospectivo-experiencia-S157509221500131X
Falconi M, Eriksson B, Kaltsas G, Bartsch GK, Capdevilla J, M Caplin, et al. Consensus guideline update for the management of funcional p-NETs (F-p-NETs) and non- funnctional p-NETs (NF-p-NETs). Neuroendocrinology. 2016;103(2): 153-171. DOI: https://doi.org/10.1159%2F000443171
Hofland J, Kaltsas G, De Herder WW. Advances in the diagnosis and management of well-differentiated neuroendocrine neoplasms. Endocrine Reviews. 2020;41(2): 371-403. DOI: https://doi.org/10.1210%2Fendrev%2Fbnz004
Guzman YF, López RP, Vera A, González-Devia Deyanira. Herramientas para el abordaje diagnóstico de los tumores neuroendocrinos de páncreas. Rev Colomb Cir. 2018;33:79-99. DOI: https://doi.org/10.30944/20117582.50
Tobón-Ospina C, Castaño P, Gutiérrez-Restrepo J, Torres-Grajales JL, Hoyos-Duque SI, Pérez-Cadavid JC, et al. Descripción de la experiencia en paciente diagnosticados con insulinomas. Estudio multicéntrico en Medellín, Colombia. Iatreia. 2020;33(2):133-142. https://hdl.handle.net/10495/20114
Jiménez JP. Insulinoma: Diagnóstico y manejo. Rev med Costa rica y Centroamer. 2014;613:845-847. https://www.medigraphic.com/pdfs/revmedcoscen/rmc-2014/rmc145zb.pdf
Okabayashi T, Shima Y, Sumiyoshi T, Kozuki A, Ito S, Ogawa Y, et al. Diagnosis and management of insulinoma. World J Gatroenterol. 2013;19(6):829-837. DOI: https://doi.org/10.3748%2Fwjg.v19.i6.829
Sada A, Glasgow AE, Vella A, Thompson GB, McKenzie TJ, Habermann EB. Malignant insulinoma: a rare form of neuroendocrine tumor. World J Surg. 2020;44(7):2288-2294. DOI: https://doi.org/10.1007/s00268-020-05445-x
Sada A, Yamashita TS, Glasgow AE, Habermann EB, Thompson GB, Lyden ML, et al. Comparison of benign and malignant insulinoma. Am J Surg. 2021;221(2):437-47. DOI: https://doi.org/10.1016/j.amjsurg.2020.08.003
Pérez AS, Gutiérrez J. Insulinoma. Medicentro Electron. 2022;26(4):995-1001. DOI: https://medicentro.sld.cu/index.php/medicentro/article/view/3762/3016
Giannis D, Moris D, Karachaliou GS, Tsilimigras D, Karoalanis G, Papalampros A, et al. Insulinomas: from diagnosis to treatment. A review of the literature. J BUON. 2020;25(3):1302-1314. https://pubmed.ncbi.nlm.nih.gov/32862570/
Copyright (c) 2023 Universidad del Cauca
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
.png)
